Epstein-Barr Virus

Infectious Disease·MeSH: Epstein-Barr Virus Infections

4 drugs in development·3 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(3)

Drug	Company
posoleucel	Kalaris Therapeutics, Inc. (KLRS)
Tab-cel (Ebvallo)	Atara Biotherapeutics, Inc. (ATRA)
tabelecleucel	Atara Biotherapeutics, Inc. (ATRA)

Phase 4(1)

Drug	Company
mrna-1189	Moderna, Inc. (MRNA)

BioSniper tracks 4 drugs in development for Epstein-Barr Virus across 3 companies.

There are 1 clinical trial targeting Epstein-Barr Virus tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.